Clinical Trial Update: LISA vs INSURE in the Treatment of Respiratory Distress Syndrome in Preterm Infants [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing LISA versus INSURE for treatment of respiratory distress syndrome in preterm infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Infants
• Respiratory Distress Syndrome of the Newborn

Drugs mentioned

• InSurE
• LISA

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Preterm Infants | Phase 2 | Status: UNKNOWN